South Korea's Samsung Biologics (207940.KS) announced on Tuesday two deals with Pfizer (PFE.N) worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant.The latest deals will see the biotech division of the Samsung Group prod
South Korea's Samsung Biologics (207940.KS) announced on Tuesday two deals with Pfizer (PFE.N) worth a combined $897 More...
https://www.emirates247.com/business/corporate/samsung-biologics-unveils-897-mln-manufacturing-deals-for-pfizer-2023-07-05-1.713852
Comments
0 comment